Our website uses cookies to make navigation as functional as possible and to perform statistics on its usage. Should you wish to receive more information, or deny your consent to all or some of the cookies, please click here. By continuing to browse this website, you will be accepting our cookies.
More info

News & Events

16 Sep 2020
InVitro Diagnostics and COVID-19
Monday, 5th October 2020 - Digital event
Read More
16 Sep 2020
COVID-19: Menarini launches an antigen test that measures viral load
The new test from A. Menarini Diagnostics to detect the presence of antigens can not only determine in just 12 minutes whether a patient is positive for COVID-19, but it also provides an indication of the viral load.
Read More
08 Sep 2020
Virtual EASD Annual Meeting 2020
Read More
07 Sep 2020
A.MENARINI DIAGNOSTICS and BIOACTIVA DIAGNOSTICA GMBH SIGN AN EXCLUSIVE AGREEMENT FOR LIOFERON® TB/LTBI, A TEST TO DIAGNOSE LATENT TUBERCULOSIS INFECTION.
Read More
02 Sep 2020
German Minister of Health Jens Spahn receives briefing on Menarini Diagnostics fast and reliable COVID VitaPCR® POC instrument.
On August 20th the German Minister of Health, Jens Spahn visited the Red Cross Hospital of Mölln-Ratzeburg. Key aspects of the visit were to identify how hospitals that are in the frontline, are competing against the COVID-...
Read More
24 Jul 2020
A.Menarini Diagnostics Announces Agreement with Skyla Corporation in the area of Point of Care Testing
Florence-based A. Menarini Diagnostics, part of the Menarini Group, and Taiwan-based Skyla Corporation, part of the Lite-On group...
Read More
16 Jul 2020
Menarini Diagnostics announces Technology Transfer Agreement to develop its own COVID 19 RT PCR assay
Florence and Trieste, Italy, July 16th, 2020
Read More
25 Jun 2020
Continuous blood glucose monitoring: the Menarini Diagnostics digital “patch” now available !
Measuring blood sugar several times a day for people with diabetes, will no longer be necessary. Menarini Diagnostics has launched GlucoMen® Day CGM, an innovative digital patch, wearable for fifteen days in a row, which moni...
Read More
02 Apr 2020
Credo Diagnostics Biomedical and A. Menarini Diagnostics sign an Exclusive Distribution Agreement for SARS-CoV-2 assay on the VitaPCRTM platform
Menarini will immediately begin the distribution of SARS-CoV-2 assay and other respiratory assays, which includes Influenza A&B, Influenza A&B + Respiratory Syncytial Virus (RSV) panel, and group A Streptococcus (group A stre...
Read More
28 Jan 2020
Innovation Zed Ltd. and A. Menarini Diagnostics, part of the Menarini Group, Enter Commercial Agreement for International Distribution of Innovative Insulin Pen “InsulCheck Connect” device
Dublin, Ireland, and Florence, Italy 28th January 2020
Read More

Our Values

10 core values have influenced the progress of our group.

READ MORE »